Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Asymchem Laboratories Tianjin CoASLTY +9.40%69 Price-to-Tangible-Book is 2.33 as of Aug. 17, 2026, which is 69% below its 10-year median of 7.48. GuruFocus rates ASLTY with a GF Score™ of 69/100 and a GF Value™ of $4.76 (Significantly Overvalued). The stock has 9 warning signs investors should review. Among 1,134 Biotechnology companies, Asymchem Laboratories Tianjin Co ranks worse than 56% on this metric.
The historical rank and industry rank for Asymchem Laboratories Tianjin Co's Price-to-Tangible-Book or its related term are showing as below:
ASLTY'
s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.54 Med: 7.48 Max: 17.7
Current: 3.56
During the past 13 years, Asymchem Laboratories Tianjin Co's highest Price to Tangible Book Ratio was 17.70. The lowest was 1.54. And the median was 7.48.
ASLTY's Price-to-Tangible-Book is ranked worse than 56% of 1134
companies
in the Biotechnology industry
Industry Median: 3.175
vs ASLTY: 3.56
Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.
Asymchem Laboratories Tianjin Co Price-to-Tangible-Book Related Terms
Asymchem Laboratories Tianjin Co Price-to-Tangible-Book Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Asymchem Laboratories Tianjin Co Price-to-Tangible-Book Chart
ASLTY vs VRTX, REGN, RVMD: Price-to-Tangible-Book Comparison
For the Biotechnology subindustry, Asymchem Laboratories Tianjin Co's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Asymchem Laboratories Tianjin Co Price-to-Tangible-Book vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Asymchem Laboratories Tianjin Co's Price-to-Tangible-Book distribution charts can be found below:
* The bar in red indicates where Asymchem Laboratories Tianjin Co's Price-to-Tangible-Book falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.
Asymchem Laboratories Tianjin Co (ASLTY) has a Price-to-Tangible-Book of 2.33 as of Aug. 17, 2026. Price-to-tangible-book ratio is the ratio of share price to a company's tangible book value per share. View historical data on Asymchem Laboratories Tianjin Co and its competitors. This is 69% below median its historical median of 7.48. Over the past decade, Asymchem Laboratories Tianjin Co's Price-to-Tangible-Book has ranged from 1.54 to 17.70. According to the industry distribution chart, Asymchem Laboratories Tianjin Co ranks #635 out of 1134 companies in the Biotechnology industry, placing it in the top 56%.
Is Asymchem Laboratories Tianjin Co's Price-to-Tangible-Book too high?
Asymchem Laboratories Tianjin Co's current Price-to-Tangible-Book of 2.33 is 69% below median its 10-year median of 7.48. Over the past 10 years, this metric has ranged from a low of 1.54 to a high of 17.70. The Biotechnology industry median Price-to-Tangible-Book is 3.18. Asymchem Laboratories Tianjin Co's value of 2.33 is 26.6% below this industry median. Based on the distribution chart, Asymchem Laboratories Tianjin Co ranks #635 out of 1134 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Asymchem Laboratories Tianjin Co has a GF Score™ of 69/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Asymchem Laboratories Tianjin Co's Price-to-Tangible-Book compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Asymchem Laboratories Tianjin Co ranks #635 out of 1134 companies for Price-to-Tangible-Book. This places Asymchem Laboratories Tianjin Co in the lower half of its industry. The industry median Price-to-Tangible-Book is 3.18. Asymchem Laboratories Tianjin Co's value of 2.33 is 26.6% below this benchmark. Historically, Asymchem Laboratories Tianjin Co's own Price-to-Tangible-Book has ranged from 1.54 to 17.70 over the past decade. While the company's 10-year median is 7.48 vs. the industry median of 3.18, Asymchem Laboratories Tianjin Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Price-to-Tangible-Book for a Biotechnology company?
The median Price-to-Tangible-Book among Biotechnology companies is 3.18, based on 1,134 companies in the industry. Companies in the top quartile (top 25%) have a Price-to-Tangible-Book significantly above this median, while those in the bottom quartile fall well below. However, Price-to-Tangible-Book should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Asymchem Laboratories Tianjin Co's current Price-to-Tangible-Book of 2.33 is 26.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Price-to-Tangible-Book mean?
A high Price-to-Tangible-Book can signal that a stock is expensive relative to its fundamentals. Price-to-tangible-book ratio is the ratio of share price to a company's tangible book value per share. View historical data on Asymchem Laboratories Tianjin Co and its competitors. For the Biotechnology industry, the median Price-to-Tangible-Book is 3.18 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Asymchem Laboratories Tianjin Co's current Price-to-Tangible-Book is 2.33, which is 69% below median its own 10-year median of 7.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asymchem Laboratories Tianjin Co stock overvalued right now?
Based on GuruFocus' analysis, Asymchem Laboratories Tianjin Co (ASLTY) is currently considered Significantly Overvalued. The stock's GF Value™ is $4.76, compared to a current price of $8.15 — trading 71.2% above its estimated fair value. The current Price-to-Tangible-Book is 2.33, which is 69% below median its 10-year median of 7.48 and 26.6% below the Biotechnology industry median of 3.18. Asymchem Laboratories Tianjin Co's overall GF Score™ is 69/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Price-to-Tangible-Book calculated?
Price-to-Tangible-Book is calculated from a company's financial statements. For Asymchem Laboratories Tianjin Co (ASLTY), the current Price-to-Tangible-Book is 2.33 as of Aug. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Asymchem Laboratories Tianjin Co (ASLTY) Overvalued in 2026?
Based on GuruFocus' analysis, Asymchem Laboratories Tianjin Co stock appears to be overvalued.
The current stock price of $8.15 is trading 71.2% above its estimated GF Value™ of $4.76.
GuruFocus considers Asymchem Laboratories Tianjin Co to be Significantly Overvalued.
Key valuation signals for ASLTY:
Price-to-Tangible-Book: 2.33 (69% below median its 10-year median of 7.48)
GF Value™: $4.76 vs. price of $8.15 (71.2% above fair value)
Industry Position: 26.6% below the Biotechnology median (#635 of 1134)
No single metric tells the full story. See the ASLTY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Asymchem Laboratories Tianjin Co Ltd is a China-based company, a technology-driven provider of Contract Development and manufacturing organization solutions throughout the drug development and manufacturing process. The group provides clinical-stage CDMO solutions, commercial-stage CDMO solutions, and emerging services. Its operations relate to contract development and manufacturing, which focus on innovation and commercial application of pharmaceutical technology. It has geographic areas in the Chinese Mainland and Overseas.
69GF Score
Get the complete analysis for ASLTY
Price-to-Tangible-Book is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASLTY has been successfully added to your 
